Regulation of Glycolytic Oscillations by Mitochondrial and Plasma Membrane H+-ATPases  by Olsen, Lars Folke et al.
3850 Biophysical Journal Volume 96 May 2009 3850–3861Regulation of Glycolytic Oscillations by Mitochondrial and Plasma
Membrane Hþ-ATPases
Lars Folke Olsen,†* Ann Zahle Andersen,‡ Anita Lunding,† Jens Christian Brasen,† and Allan K. Poulsen†§
†CelCom, Department of Biochemistry and Molecular Biology, University of Southern Denmark, Odense, Denmark; ‡Microbiology Group,
Department of Biochemistry and Molecular Biology, University of Southern Denmark, Odense, Denmark; and §Danish Technological Institute,
A˚rhus, Denmark
ABSTRACT We investigated the coupling between glycolytic and mitochondrial membrane potential oscillations in Saccharo-
myces cerevisiae under semianaerobic conditions. Glycolysis was measured as NADH autoﬂuorescence, and mitochondrial
membrane potential was measured using the ﬂuorescent dye 3,30-diethyloxacarbocyanine iodide. The responses of glycolytic
and membrane potential oscillations to a number of inhibitors of glycolysis, mitochondrial electron ﬂow, and mitochondrial and
plasma membrane Hþ-ATPase were investigated. Furthermore, the glycolytic ﬂux was determined as the rate of production
of ethanol in a number of different situations (changing pH or the presence and absence of inhibitors). Finally, the intracellular
pH was determined and shown to oscillate. The results support earlier work suggesting that the coupling between glycolysis
and mitochondrial membrane potential is mediated by the ADP/ATP antiporter and the mitochondrial F0F1-ATPase. The results
further suggest that ATP hydrolysis, through the action of the mitochondrial F0F1-ATPase and plasma membrane H
þ-ATPase,
are important in regulating these oscillations. We conclude that it is glycolysis that drives the oscillations in mitochondrial
membrane potential.INTRODUCTION
Oscillatory behavior is known to occur in many different bio-
logical settings. Some examples are the circadian rhythms,
the mitotic oscillator, oscillations in cyclic AMP in Dictyos-
telium cells, and oscillations in free calcium in numerous
types of cells (1). In addition, many metabolic processes
are known to oscillate (2–7). The best-known metabolic
oscillator is probably glycolysis in the yeast strain Saccharo-
myces cerevisiae, but oscillating glycolysis is also found in
other cells, e.g., muscle cells and pancreatic b-cells (3).
Mitochondria are best known for their role in energy metab-
olism. However, it has recently become clear that mitochondria
serve many other functions in the cell. In some cells, e.g.,
neutrophils, the mitochondria are responsible only for a minor
part of the ATP production. Instead, it appears that these organ-
elles participate in calcium homeostasis and in apoptosis
(8–10). In pancreatic b-cells, the mitochondria serve an impor-
tant role in the regulation of insulin production, in addition to
providing the cells with ATP. Glycolytic oscillations in b-cells
are in part regulated by the mitochondria. The resulting oscil-
lations in ATP in turn regulate ion channels in the plasma
membrane, generating an oscillating membrane potential,
which again controls oscillations in cytoplasmic free calcium
and the release of insulin (11). Recently, we reported a similar
coupling between an oscillating glycolysis in S. cerevisiae and
mitochondrial membrane potential (Dcm) (12,13). It is not yet
known whether it is the same coupling that is responsible for
other oscillations involving mitochondria, e.g., the synchro-
nized oscillations observed in respiration of S. cerevisiae in
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chondrial function seems to regulate a number of cellular
processes, because it was shown that the majority of metabo-
lites in the cells show oscillatory dynamics with 70% of the
identified metabolites peaking in conjunction with nicotin-
amide adenine dinucleotide (NAD(P)H) (17).
Oscillations in yeast glycolysis, as observed in oscillations
in NADH autofluorescence, involve anaerobic or semianaero-
bic conditions (18–21). The latter implies that cyanide has
been added to the cells to arrest respiration. Glycolytic oscil-
lations in yeast represent a collective phenomenon. Thus, a
single isolated cell displays no oscillations, whereas a suspen-
sion of yeast cells will show oscillations, in which all cells
oscillate in phase when a certain critical cell density is reached
(22,23). This contrasts with the observed oscillations in
NAD(P)H and Dcm in single yeast cells under aerobic condi-
tions, which, despite individual cells being synchronized,
apparently are independent of cell density (24).
The oscillations in yeast glycolysis are accompanied by
oscillations inDcm (12). However, the mechanism responsible
for these membrane potential oscillations is not yet
fully understood. Furthermore, it remains uncertain whether
the phenomenon represents a coupling between two autono-
mous oscillators (24,25)—glycolysis and mitochondria—or
whether glycolysis drives the oscillations in Dcm. A coupling
between yeast glycolysis and Dcm was previously proposed
to involve the mitochondrial ADP/ATP antiporter, the F0F1-
ATPase, and possibly also components of the respiratory chain
(13). This conjecture was based on the observed effects of
the inhibitors atractyloside and dicyclohexylcarbodiimide
(DCCD). Atractyloside inhibits the mitochondrial ADP/
ATP antiporter (26), whereas DCCD inhibits the proton
doi: 10.1016/j.bpj.2009.02.026
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have more unspecific effects on respiration at higher concentra-
tions (27,28). High concentrations (100mM or more) of DCCD
have also been shown to inactivate the plasma membrane Hþ-
ATPase of the yeast Kluyveromyces lactis (29). Thus, the
observed effect of DCCD on the oscillations (13) could also
be due to an effect on this enzyme in S. cerevisiae.
In our study, we have performed simultaneous measure-
ments of oscillations in NADH and Dcm in S. cerevisae,
and we have investigated the effect of various inhibitors of
glycolysis, mitochondrial electron transport, and mitochon-
drial and plasma membrane Hþ-ATPases on the oscillations.
We found that NADH and Dcm oscillate in phase. Further-
more, we have found that inhibitors of mitochondrial
electron transport have no effect on oscillations in neither
NADH nor Dcm, whereas inhibitors of glycolysis inhibit
both types of oscillations. Inhibitors of plasma membrane
Hþ-ATPases seem to stimulate the amplitude of oscillations
in Dcm at low concentrations, but they inhibit them at higher
concentrations. Moreover, we have measured intracellular
pH and found that, in addition to showing fairly large
changes (up to 0.5 pH unit) because of the action of the
two Hþ-ATPases and the formation of HCO3
-, intracellular
pH (pHi) also oscillates. These oscillations are due either
to oscillations in bicarbonate or to the activity of the plasma
membrane Hþ-ATPase. Our results are in agreement with the
idea that it is glycolysis that drives the oscillations in Dcm.
Furthermore, our results show that the activities of mitochon-
drial and plasma membrane proteins are important for the
control of glycolysis, and they suggest that the ATP/ADP
ratio is the link between the two oscillating systems.
MATERIALS AND METHODS
Reagents
All reagents were purchased from Sigma-Aldrich (Munich, Germany), except
for the fluorescent probes 3,30-diethyloxacarbocyanine iodide (DiOC2(3))
and 20,70-bis (2-carboxyethyl), 5 (and -6) carboxyfluorescein (BCECF),
which were obtained from Molecular Probes (Eugene, OR), and the ATP
determination kit, which was obtained from Biaffin (Kassel, Germany).
Yeast cells
Yeast cells, Saccharomyces cerevisiae diploid strain X2180, were grown
and harvested as described in Poulsen et al. (21). The cells were starved
for 3 h at room temperature in 100 mM sodium phosphate buffer, pH 6.8,
before use. In all measurements, except for measurements of plasma
membrane Hþ-ATPase activity and intracellular pH (see section, Measure-
ments of intracellular pH), the cells were suspended in 100 mM phosphate
buffer, pH 6.8.
Mass spectrometric measurements of oxygen
consumption and CO2 and ethanol production
Measurements of the consumption of oxygen and the production of CO2 and
ethanol were conducted by use of membrane inlet mass spectrometry, as
described in Poulsen et al. (21).Omeprazole treatment and measurements of
proton pumping in intact yeast cells
Omeprazole was dissolved in 0.1 N HCl and left for at least 10 min before
being added to the yeast suspension. Yeast cells were suspended in 250 mM
sorbitol, and various amounts of omeprazole solution were added to the
suspension (concentration range 0–250 mM). The pH was adjusted with
HCl at 3.0–3.2. After 10 min the suspension of cells was centrifuged at
18,000 rpm for 2 min in a small bench top centrifuge (Ole Dich Instrument-
makers, Copenhagen, Denmark). The resulting pellet was resuspended in fresh
250 mM sorbitol for measurements of proton pumping activity, or in 100 mM
phosphate buffer, pH 6.8, for measurements of NADH and Dcm or pHi.
To measure proton pumping activity, the cells were first suspended in
100 mM phosphate buffer and stored on ice for 2 h to reduce metabolic
activity to a minimum. They were then treated with omeprazole as described
above and resuspended in 250 mM sorbitol to a density of 2% wet weight. The
initial pH was adjusted with HCl or NaOH to pH 5.1, and 30 mM glucose was
added to the suspension. The rate of proton pumping was measured as the
initial slope of the pH-change immediately after addition of glucose. pH
was measured either using a pH-meter or by recording the fluorescence of
20,70-bis (2-carboxyethyl), 5 (and -6) BCECF (excitation 470/20 nm, emission
540/10 nm), using the Ocean Optics QE65000 spectrometer (see section,
Fluorescence measurements).
Measurements of intracellular pH
Measurements of the pHi in a suspension of yeast cells with oscillating glycol-
ysis were performed essentially as described by Halm et al. (30): To a 2 mL
suspension of yeast cells (10% wet weight) were added 3 mL of 4.5 mM
5- (and -6-) carboxyfluorescein diacetate succinimidyl ester (CFSE) in
dimethyl sulfoxide. The suspension was mixed thoroughly and incubated at
40C for 20 min. and then immediately centrifuged at 7000  g for 3 min.
The supernatant was discarded and the pellet was suspended in 100 mM phos-
phate buffer, pH 6.8, unless otherwise indicated, and stored at 4C until use.
pHi was measured as the ratio of the emissions at 520/1 nm, using excitations
of 490/3 nm and 435/3 nm, respectively (30,31). A calibration curve was con-
structed by first permeabilizing the cells with 70% ethanol for 30 min at 30C
(30). The cells were then resusupended in a citric acid/sodium phosphate
buffer at pH values ranging from 5.5 to 8.5 and stained with 5- (and -6-)
CFSE, as described above. The calibration curve is shown in Fig. S1 in the
Supporting Material. The data could be fitted to a Henderson-Hasselbalch
type equation:
R490=435 ¼ 2 þ 10
pH7
1 þ 10pH7: (1)
The number 2 represents the limit of R490=435 at low pH. The relationship
between pH and R490/435 found in our study is essentially identical to that
found by Halm et al. (30).
Measurements of intracellular ATP
Measurements of the average intracellular ATP concentration were made
by first quenching the cells with boiling buffered ethanol and subsequently
extracting the metabolites as described by Gonzales et al. (32). The ATP
concentration in the extract was then measured using the Biaffin ATP
determination kit. The cells’ protein content was determined according to
Lowry et al. (33).
Fluorescence measurements
Simultaneous measurements of NADH autofluorescence and membrane
potential-dependent DiOC2(3) fluorescence were made in a QE65000 spec-
trometer (Ocean Optics, Dunedin, FL) fitted with a temperature-controlled
cuvette holder. Temperature was 25  0.02C. Light was supplied by two
Hg-lamps (model St75; Heraeus, Hanau, Germany) powered by two NTBiophysical Journal 96(9) 3850–3861
3852 Olsen et al.HgSt power supplies (Duratec Analysentechnik, GmBH, Hockenheim,
Germany). The light from the lamps was guided to the measuring cell using
optical fibers (Rapp Optoelectronic, GmBH, Hamburg, Germany) mounted
perpendicular to the emission light beam. NADH was excited using an inter-
ference filter (355/20 nm) (Edmund Optics Inc., Barrington, NJ), and the
emission was measured as the average intensity in the wavelength range
445–470 nm. DiOC2(3) was excited using an Edmund Optics interference
filter (500/24 nm), and the emission was measured as the average intensity
in the wavelength range 580–620 nm or as the average fluorescence intensity
in the range 530–550 nm. A plot of the average fluorescence in the range 530–
550 nm against the average fluorescence in the range 580–620 nm gave
a straight line with positive slope (data not shown). The autofluorescence
measurements of NADH at wavelengths 530–550 nm and 580–620 nm
were also taken and found to be negligible compared with the fluorescence
of DiOC2(3) at these wavelengths; thus, there was no need to correct for
contributions from NADH fluorescence. The pH-dependent fluorescence of
BCECF was measured using an Edmund Optics interference filter (472/20)
for excitation, and the emission was measured as the average fluorescence
intensity in the range 530–550 nm. NADH autofluorescence (excitation
366/3 nm, emission 450/10 nm) and membrane potential-dependent
DiOC2(3) fluorescence (excitation 488/3 nm, emission 600/3 nm) were also
measured by an FS910 spectrofluorometer (Edinburgh Instruments, Edin-
burgh, Scotland). Measurements of intracellular pH were performed withBiophysical Journal 96(9) 3850–3861the Edinburgh FS910 spectrofluorometer by measuring the ratio of the exci-
tations at 490/3 nm over the excitation at 435/3 nm (emission 520/1 nm).
Thus, pHi had to be measured in two separate experiments. The advantage
of using the Ocean Optics spectrofluorometer is that this instrument allows
for simultaneous measurements of two events such as NADH fluorescence
and the fluorescence from DiOC2(3). However, the sensitivity of this instru-
ment is a factor 102 lower than the sensitivity of the Edinburgh Instruments
spectrofluorometer. The cells were suspended in a stirred 2 mL sample in
a 1 cm 1 cm  4.5 cm quartz cuvette. When measuring mitochondrial
membrane potential, cells were supplied with 2–6 mM DiOC2(3) at time 0,
as described in Andersen et al. (12).
All experiments shown were repeated 3–5 times and were very reproducible.
RESULTS
Measurements of oscillations of NADH and Dcm
Our previous work has shown that the red fluorescence of
the carbocyanine dye DiOC2(3) measures almost exclusively
Dcm (12). Fig. 1, A–D shows the simultaneous measure-
ments of NADH and Dcm. An increase in DiOC2(3)FIGURE 1 Time series of NADH fluorescence (A, C),
DiOC2(3) fluorescence (B, D), and phase plot of
DiOC2(3) fluorescence vs. NADH fluorescence (E). Yeast
cells were suspended in 100 mM phosphate buffer, pH 6.8,
to a cell density of 10% wet weight. At time 0, 4 mM
DiOC2(3) were added to the suspension. At times ~180 s
and 240 s, 30 mM glucose and 5 mM KCN were added
to the suspension, respectively. Temperature, 25C.
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membrane potential, whereas a decrease in fluorescence
corresponds to a depolarization of membrane potential (12).
We noted that there is no apparent phase shift in the two oscil-
lations (Fig. 1, C and D). This observation is substantiated by
the phase plot (Fig. 1 E) that reveals a straight line. Similar
measurements of green fluorescence of DiOC2(3) (530–550
nm), as well as measurements using a lower concentration
(2 mM) of the dye DiOC2(3), gave identical results to those
shown in Fig. 1. Thus, because the signal/noise ratio is higher
using the spectral region 530–550 nm, we performed the
remaining measurements of Dcm using this green fluores-
cence. This also allowed us to use concentrations of the dye
down to 2 mM, which is well below the critical toxic limit
of 6 mM (12).
We have previously shown (12,13) that the oscillations in
NADH and Dcm are tightly coupled and that the only way to
uncouple them is by adding carbonylcyanide p-trifluorome-thoxyphenylhydrazone (FCCP). Immediately after addition
of 20 mM FCCP, Dcm is dissipated, whereas the oscillations
in NADH continue relatively unaffected (12). Here we have
investigated how the oscillations of NADH and Dcm respond
to incubating the yeast cells with low and high concentra-
tions of FCCP. Fig. 2 shows the effect on NADH oscillations
and oscillations in Dcm of preincubating yeast cells for
10 min with low concentrations (%1mM) of FCCP. Note
that, whereas the size of Dcm and the amplitude of its
oscillations decrease (right panel), the size of the autofluor-
escence of NADH and the amplitude of its oscillations are
relatively unaffected by FCCP at these low concentrations
(left panel). We were unable to detect any effect of FCCP
on the frequency of either of the two types of oscillations.
Whereas higher concentrations of FCCP only have the
immediate effect of dissipating Dcm, leaving the oscillations
in NADH intact (12), we found in our study that exposure to
more than 5 mM FCCP for 10 min annihilates oscillations ofFIGURE 2 Effect of low (%1mM) concentrations of
FCCP on oscillations of NADH and mitochondrial
membrane potential. (A, B) Control. (C, D) 250 nM
FCCP. (E, F) 500 nM FCCP. (G, H) 1 mM FCCP. The cells
were incubated with the indicated concentrations of FCCP
for 10 min before being transferred to the measuring cell.
Other conditions as in Fig. 1.Biophysical Journal 96(9) 3850–3861
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of the cells to a combination of atractyloside and FCCP
blocked the oscillations completely.
To reveal more about the mechanism responsible for the
coupling between the dynamics of NADH andDcm,we tested
the effect of a number of inhibitors of the glycolytic pathway
and respiration on the oscillations. The results are summarized
in Table S1. The effects of the inhibitors 2-deoxyglucose and
iodoacetate clearly demonstrate that glycolysis controls the
oscillations of both NADH and Dcm. 2-Deoxyglucose is
phosphorylated in a reaction catalyzed by hexokinase (34).
However, the deoxyglucose-6-phosphate formed cannot be
metabolized further, and hence ATP production by the
lower part of glycolysis is inhibited, resulting in a decrease
in glucose consumption and accumulation of intracellular
glucose (13,34). Iodoacetate is an inhibitor of glyceralde-
hyde-3-phosphate dehydrogenase (35). The effect of iodoace-
tate on oscillations of NADH andDcm is shown in Fig. 3. Note
that, whereas addition of iodoacetate results in termination of
the oscillations of NADH andDcm, as well as a decrease in the
amount of NADH, Dcm remains hyperpolarized. Similarly,
addition of amphotericin B, which induces leakage of Kþ
out of the cell and influx of protons from the environment
(31), inhibits the oscillations of both NADH andDcm. Hence,
the loss of intracellular Kþ might inhibit Kþ-dependent
enzymes such as aldolase, phosphofructokinase, and pyruvate
kinase (36) and result in loss of the oscillations. The disappear-
ance of the oscillations is accompanied by a slow depolariza-
tion of Dcm. (data not shown).
Addition of 5 mM azide resulted in a complete halt of the
oscillations of NADH and Dcm and a decrease in the magni-
tude of Dcm (data not shown). To test if there was any differ-
ence in the effect of azide on the two types of oscillations, we
incubated yeast cells with lower concentrations of azide
(Fig. 4). Note that, as opposed to the effect of FCCP, azide
affects the oscillation amplitudes of NADH andDcm equally.
In addition, the magnitude of Dcm is reduced. As to the effect
of azide, it is an inhibitor of several processes in the mitochon-
dria: (i), it inhibits respiration at complex IV (cytochrome c
oxidase) (37); (ii), it inhibits so-called ‘‘nonrespiratory oxygen
consumption’’ in S. cerevisiae (38); and (iii), it is a strong
inhibitor of ATP hydrolysis by the mitochondrial F0F1-Biophysical Journal 96(9) 3850–3861ATPase (39). Concerning a potential effect on complex IV,
we have already added cyanide, which blocks respiration.
Measurements using membrane-inlet mass spectrometry
showed that there was no oxygen consumption by the yeast
cells in the presence of 5 mM cyanide, and further addition
of 5 mM azide could therefore not increase this inhibition.
Furthermore, addition of 5 mM salicylhydroxamic acid
(SHAM), which was shown to inhibit nonrespiratory oxygen
consumption (38), did not have any effect on the oscillations
(data not shown). This leaves us with the effect of azide on
the activity of F0F1-ATPase. In a previous report we proposed
that, in addition to the ADP/ATP antiporter, F0F1-ATPase is
involved in the coupling of glycolytic oscillations to oscilla-
tions in Dcm (13). The observed effect of azide strongly
supports this hypothesis.
Dcm can be generated by reversing the F0F1-ATPase such
that protons are pumped out of the matrix into the cytosol
while ATP is being hydrolyzed. This results in the generation
of a pH gradient and a membrane potential (proton-motive
force). However, a proton-motive force may also be generated
if parts of the mitochondrial electron transport chain are
still active, even when respiration has been inhibited by
cyanide. We therefore tested if a part of the mitochondrial
electron transport chain could be involved in the generation
of Dcm oscillations. However, antimycin A, which inhibits
complex III (ubiquinol:cytochrome c oxidoreductase), did
not have any effect on the oscillations (Table S1). Membrane-
inlet mass spectrometry measurements, performed under
aerobic conditions in the absence of cyanide, showed an
almost 100% inhibition of respiration by antimycin A at the
concentrations used in Table S1. Addition of antimycin (or
of any of the other inhibitors listed in Table S1) instead of
cyanide did not induce long trains of oscillations in NADH
and Dcm. At most, we observed a damped oscillation with
2–3 excursions if we added, e.g., antimycin instead of cyanide
after a pulse of glucose.
We have previously shown that DCCD inhibits the oscilla-
tions of both NADH and Dcm (13), suggesting the involve-
ment of F0F1-ATPase in the oscillations in Dcm. However,
the effect of DCCD is not specific (27–29): At low concentra-
tions it mainly inhibits the F0F1-ATPase, whereas at higher
concentrations, as used in our previous study (13), it alsoFIGURE 3 Effect of iodoacetate on oscillations of
NADH and Dcm . Yeast cells were suspended to a density
of 10% wet weight in 100 mM phosphate buffer and
DiOC2(3), glucose and KCN were added as described in
Fig. 1. At time ~1000 s, 20 mM iodoacetate was added
to the suspension.
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mitochondrial membrane potential. Yeast cells were sus-
pended in 100 mM phosphate buffer, pH 6.8, to a density
of 10% wet weight and incubated with 0 (A, B), 100 mM
(C, D), 200 mM (E, F), and 400 mM (G, H) sodium azide
for 10 min before being transferred to the measuring cell.
Other conditions as in Fig. 1.inhibits the plasma membrane Hþ-ATPase of some yeast
strains (29). This Hþ-ATPase may account for up to 60% of
the ATP hydrolysis in the cell (31). To investigate whether
other inhibitors of the plasma membrane Hþ-ATPase could
affect the oscillations, we tested the effect of omeprazole,
which is a strong inhibitor of the Hþ-Kþ-ATPase of the
gastric mucosa (40). Omeprazole has also been shown to
inhibit other P-ATPases, including the S. cerevisiae plasma
membrane Hþ-ATPase (41). Fig. 5 shows the effect of ome-
prazole on the Dcm oscillations. The oscillations of NADH
could not be recorded properly at high concentrations
(>100 mM) of omeprazole, because omeprazole has a strong
absorption in the UV region and therefore reduces the fluores-
cence of NADH considerably. However, addition of omepra-
zole did not cause a significant change in the amplitude of
NADH oscillations at concentrations up to 100 mM (data
not shown). The recordings of Dcm (Fig. 5) show that, at
low concentrations of omeprazole, the amplitude of Dcm
oscillations increases with the omeprazole concentration untilit reaches a maximum at ~100 mM of the inhibitor, and then it
decreases again. At a concentration of 250 mM omeprazole,
the amplitude decreased to below the initial level. Further-
more, the size of Dcm increases with increasing omeprazole
concentrations. Fig. 6 A shows a plot of the relative amplitude
of the Dcm oscillation against the omeprazole concentration.
Unlike the amplitude (Fig. 6 A), the frequency of Dcm oscil-
lations remained constant with changing omeprazole concen-
tration (Fig. 5 A). Measurements of the activity of the plasma
membrane Hþ-ATPase against the concentration of omepra-
zole are shown in Fig. 6 B. We noted that the activity of the
plasma membrane Hþ-ATPase decreases monotonically
with the omeprazole concentration.
Mass-spectrometric measurements of glycolytic
ﬂux
The increase in Dcm could be associated with an increase
in ATP concentration caused by the decrease in plasmaBiophysical Journal 96(9) 3850–3861
3856 Olsen et al.FIGURE 5 Effect of omeprazole on oscillations of mito-
chondrial membrane potential. Yeast cells (10% wet
weight) suspended in 250 mM sorbitol were treated for
10 min with omeprazole, as described in the ‘‘Materials
and Methods’’ section. After centrifugation the cells were
suspended (10% wet weight) in 100 mM phosphate buffer
and transferred to the measuring cell. The following
concentrations of omeprazole were added to the cells: (A)
0 mM; (B) 100 mM; (C) 150 mM; and (D) 250 mM. Other
conditions as in Fig. 1.membrane Hþ-ATPase activity. Such an increase in ATP
concentration could again lead to an overall decrease in glyco-
lytic flux (42) because of limitations in ADP in the lower part
of glycolysis. We tested whether omeprazole could induce
such a decrease in glycolytic flux by measuring the rate of
production of CO2 and ethanol in cells incubated with
omeprazole for 10 min. The results obtained with ethanol
are shown in Fig. 7. We found that treatment with 100 mM
and 250 mM omeprazole resulted in identical decreases in
the rates of CO2 and ethanol production of 17 and 29%,
respectively, consistent with the hypothesis that, if inhibition
of plasma membrane Hþ-ATPase activity leads to an increase
in intracellular ATP, then the flux through glycolysis
decreases accordingly. However, the inhibition of glycolytic
flux was somewhat less than the inhibition of plasma
membrane Hþ-ATPase activity shown in Fig. 6 B. To test if
the inhibition of the plasma membrane Hþ-ATPase did lead
to an increase in intracellular ATP, we determined the intra-
cellular ATP concentration. 30 mM glucose and 5 mM
KCN were added to a suspension of yeast cells treated with
0, 100, or 250 mM omeprazole. After 5–6 min the suspension
was transferred to boiling buffered ethanol, and the intracel-
lular metabolites were extracted as described by Gonzales
et al. (32). The protein content of the cells was measured
and the average intracellular concentration of ATP was deter-
mined, assuming an intracellular volume of 3.75 mL per mg
protein (43). The intracellular concentrations of ATP were
determined to 1.9  0.3 mM, 2.3  0.2 mM, and 2.6 
0.3 mM for cells treated with 0, 100, and 250 mM omeprazole,
respectively.
However, the decrease in glycolytic flux might also be due
to a decrease in intracellular pH caused by the inhibition of
the plasma membrane Hþ-ATPase. We therefore tested theBiophysical Journal 96(9) 3850–3861effect of pH and also the effect of various other inhibitors
on the glycolytic flux. The glycolytic flux was unaffected
by the extracellular pH in the range 4.0–8.0. As expected,
iodoacetate completely blocked the glycolytic flux, whereas
5 mM 2-dexoyglucose inhibited the flux by 50%. FCCP
increased the rate of glycolysis by 10%, whereas amphoter-
icin B, surprisingly, had no effect on the glycolytic flux. The
glycolytic flux was also unaffected by treatment with anti-
mycin A and SHAM. Addition of azide induced a slight
increase in the glycolytic flux.
Measurements of intracellular pH
We investigated, finally, whether the changes in oscillation
amplitude and glycolytic flux caused by the various inhibi-
tors of glycolysis, electron transport, and Hþ-ATPases could
be associated with changes in pHi. After incubating the yeast
cells with the pH-sensitive dye 5- (and -6-) CFSE and
measuring the ratio of exctitations at 490 nm and 435 nm
(30,31), we determined pHi by employing the calibration
curve shown in Fig. S1. An example is shown in Fig. 8.
We noted that, immediately after addition of glucose and
cyanide, pHi rose quickly from ~7.3 to 7.9 and then slowly
reverted toward the initial pHi again. Furthermore, the oscil-
lations in NADH were accompanied by oscillations in pHi. It
was only the emission from the 490 nm excitation that oscil-
lated. We observed no oscillations in the emission from the
490 nm excitation in the absence of the pH-sensitive dye.
The phase relationship between oscillations in NADH and
pHi revealed that the oscillations were in phase (data not
shown). When we performed the same experiment in phos-
phate buffer at pH 5.5, we obtained a similar result, namely
that, after addition of glucose and cyanide, pHi quickly rose
Regulation of Glycolytic Oscillations 3857from ~6.2 to ~6.7 and then slowly declined toward the initial
pHi value (see Fig. S2). Again, we observed oscillations in
pHi accompanying the oscillations in NADH.
The initial fast rise in pHi could be ascribed to the action of
the plasma membrane Hþ-ATPase (see below). The subse-
quent decline in pHi may be due partly to the formation of
bicarbonate in glycolysis and partly to the action of the mito-
chondrial F0F1-ATPase pumping protons from the mitochon-
drial matrix to the cytoplasm while hydrolyzing ATP. The
latter can be inferred from the action of FCCP, which induces
a rapid increase in pHi (see Fig. S3). This rise in pHi has the
same half time as that of the decay ofDcm observed by Ander-
sen et al. (12). Furthermore, addition of iodoacetate resulted
in a slowing down of the decline in pHi (see Fig. S4). The oscil-
lations in pHi could be associated either with the formation
FIGURE 6 Plots of the relative amplitude of Dcm oscillations (A) and the
relative plasma membrane Hþ-ATPase activity (B) against the omeprazole
concentration. Plasma membrane Hþ-ATPase activity was measured as
described in the ‘‘Materials and Methods’’ section. The error bars indicate
the standard error (n ¼ 4–5).of bicarbonate or with the activity of the plasma membrane
Hþ-ATPase. They cannot be due to the activity of the F0F1-
ATPase, because pHi continues to oscillate after Dcm and
the mitochondrial pH gradient had been dissipated by FCCP
(Fig. S3). We also measured pHi after treatment of the cells
with different concentrations of omeprazole. Fig. S5 shows
pHi before and after addition of 30 mM glucose and 5 mM
potassium cyanide to untreated cells and cells treated with
250 mM omeprazole. We determined a 57% decrease in the
ratio of the initial slope of pHi rise after addition of KCN in
the cells treated with omeprazole, as compared with results
with the control untreated cells. The experiments with omepra-
zole therefore suggest that the initial rise in pHi is because
of the activity of the plasma membrane Hþ-ATPase, and
the experiments with FCCP and iodoacetate suggest that the
subsequent slow decay in pHi is due to a combination of
the pumping of protons out of the mitochondrial matrix and
the formation of HCO3
-.
Finally, we tested the effects of amphotericin B and azide
on pHi. Addition of amphotericin B to the oscillating yeast
suspension resulted in a rapid decline in pHi to ~7 (see
Fig. S3). Incubation of yeast cells with 5 mM azide resulted
in an increase in the peak of pHi after addition of cyanide.
Addition of azide to yeast cells with an oscillating glycolysis
resulted in a complete halt of the oscillations and a slowing
down in the decline of pHi (data not shown).
DISCUSSION
Our experiments show that, in intact yeast cells, NADH au-
tofluorescence and DiOC2(3) fluorescence oscillate in phase.
FIGURE 7 Effect of omeprazole on the rate of glycolysis measured as the
production of ethanol. Yeast cells were treated with omeprazole for 10 min,
as described in the ‘‘Materials and Methods’’ section. After centrifugation
the cells were suspended in 100 mM phosphate buffer to a density of 2%
wet weight and transferred to the mass spectrometer measuring cell. At
time ~200 s, 5 mM KCN and 30 mM glucose were added to the suspension.
Ethanol was measured as the relative abundance at m/z ¼ 31.Biophysical Journal 96(9) 3850–3861
3858 Olsen et al.At present, it is uncertain how much of the NADH fluores-
cence stems from cytoplasmic or mitochondrial pools.
However, it is unlikely that mitochondrial NADH contrib-
utes to the oscillations in NADH fluorescence, because, as
shown here, no inhibitors of mitochondrial electron transport
except for cyanide and azide were found to affect the oscil-
lations. To look for a coupling between the NADH and Dcm
oscillations, one should look for species that either oscillate
in phase or 180 out of phase with NADH. Richard et al. (43)
performed experiments in which yeast cells were lysed at
different phases of the NADH oscillations and the glycolytic
intermediates were extracted and their phase relationship to
NADH was determined. It was found that ADP oscillates
in phase with NADH, whereas ATP oscillates 180 out of
phase with NADH. Thus, ADP and ATP meet the criteria
as species that could mediate the coupling between oscilla-
tions in NADH and Dcm. The results of our presented exper-
iments are therefore consistent with our previous suggestion
(12,13) that the oscillations in Dcm involve the ADP/ATP
antiporter. The failure to observe any effect on the oscilla-
FIGURE 8 Time series of NADH fluorescence and pHi. Yeast cells stained
with 5- (and -6-) CFSE were suspended in 100 mM phosphate buffer, pH 6.8,
to a cell density of 10% wet weight. At times 180 s and 240 s, 30 mM glucose
and 5 mM KCN were added to the suspension, respectively; pHi was deter-
mined from measurements of the ratio of excitations at 435 nm and 490 nm
(emission 520 nm) and the calibration curve in Fig. S1. Temperature was 25C.Biophysical Journal 96(9) 3850–3861tions of inhibitors of mitochondrial electron transport such
as antimycin A and inhibitors of nonrespiratory oxygen
consumption (SHAM) strongly suggest that electron trans-
port and the associated proton pumping by complex I-IV,
as well as other types of electron transport, do not contribute
to the generation of a membrane potential. Also, because
other inhibitors of respiratory and nonrespiratory oxygen
consumption do not have an effect on oscillations, the effect
of azide cannot be due to an inhibition of these processes.
Therefore, the blockade of both NADH and Dcm oscillations
by azide must be ascribed to its inhibition of ATP hydrolysis
by F0F1-ATPase (39). This theory is supported by the obser-
vation that the acidification of pHi is slowed down after
addition of azide, indicating that the pumping of protons
from the mitochondrial matrix to the cytoplasm is inhibited.
Hence, our presented results also suggest that, in addition
to the ADP/ATP antiporter, F0F1-ATPase is involved in
the oscillations of Dcm. This is further corroborated by the
observation that addition of high (20 mM) concentrations
of FCCP induces an increase in pHi, most likely because
of the dissipation of the proton-motive force across the mito-
chondrial membrane. This increase in pHi occurs with the
same half time as that of the decay in Dcm after addition
of FCCP (12). The rapid decay in pHi after addition of
amphotericin B should be accompanied by an increase in
the activity of the plasma membrane Hþ-ATPase. Thus,
the slow decay in Dcm after addition of amphotericin B
may be explained by a lack of ATP caused by this increase
in the activity of the Hþ-ATPase (44). The decrease in cyto-
plasmic ATP should also decrease the influx of ATP into the
mitochondria and, hence, the activity of the F0F1-ATPase,
leading to an overall depolarization of Dcm. A decrease in
cytoplasmic ATP might result in an increase in the glycolytic
flux, but the loss of Kþ might again compensate for this,
because of inhibition of Kþ-dependent enzymes in glycol-
ysis, leaving the overall glycolytic flux relatively unaffected
by amphotericin B.
The effect of low concentrations of FCCP shows that the
oscillations inDcm can be uncoupled gradually from the oscil-
lations in NADH, suggesting that Dcm oscillations are driven
by glycolytic oscillations and not vice versa. Our experiments
support the suggestion by Aon et al. (45) that mitochondrial
functions are involved in controlling glycolytic oscillations
in S. cerevisiae. However, whereas these authors proposed
that parts of the electron transport chain contribute to the gener-
ation of Dcm, our results suggest that the sole source of the
observed potential is the concerted action of the ADP/ATP
antiporter and the F0F1-ATPase.
The effects of the plasma membrane Hþ-ATPase inhibitor
omeprazole are somewhat surprising. Our measurements of
the proton pumping activity and the changes in pHi seem to
confirm that omeprazole does indeed inhibit the plasma
membrane Hþ-ATPase. Thus, at low concentrations of ome-
prazole, we observed an increase in the size ofDcm, a decrease
in plasma membrane Hþ-ATPase activity, and a decrease in
Regulation of Glycolytic Oscillations 3859overall glycolytic flux. Omeprazole was the only inhibitor
used here, apart from the inhibitors of glycolysis, to induce
a decrease in glycolytic flux. As shown by Larsson et al.
(42), a decrease in glycolytic flux may be associated with an
increase in ATP concentration. This observation is further
supported by our measurements of intracellular ATP in
cells treated with omeprazole. Therefore, when the plasma
membrane Hþ-ATPase is inhibited, the intracellular ATP
concentration increases and this again induces an increase
in F0F1-ATPase activity. Thus, the activity of the F0F1-
ATPase somewhat compensates for the decrease in plasma
membrane Hþ-ATPase activity. Hence, the net ATPase
activity shows relatively less inhibition compared with that
resulting from the plasma membrane Hþ-ATPase activity.
This suggestion is supported by the fact that, whereas omepra-
zole also inhibits the overall glycolytic rate as determined by
the CO2 and ethanol production, the degree of inhibition of
glycolysis is smaller than the degree of inhibition of the
plasma membrane Hþ-ATPase activity. It could be speculated
that the decrease in glycolytic flux might also be due to a
decrease in pHi caused by the decrease in the activity of the
plasma membrane Hþ-ATPase. However, we can rule out
this possibility, because glycolytic flux is essentially unaf-
fected by the pHi in the range 6–8. At concentrations of ome-
prazole > 100 mM, there is no additional increase in the size
of Dcm, suggesting that the F0F1-ATPase has reached its
maximum velocity. An additional interesting observation is
that, when the plasma membrane Hþ-ATPase was only
slightly inhibited by omeprazole, we observed an increase
in the amplitude of the Dcm oscillations. This could also be
explained by an increase in the activity of the F0F1-ATPase,
hence supporting the suggestion that a modest inhibition of
the plasma membrane Hþ-ATPase induces an increase in
F0F1-ATPase activity.
We have also observed oscillations in pHi. However, it is
not clear if the oscillations in pHi are due to oscillations in the
concentration of bicarbonate or to oscillations in activity of
the plasma membrane Hþ-ATPase. We have previously
observed oscillations in the external concentration of CO2
in suspensions of yeast cells exhibiting glycolytic oscilla-
tions (21). These oscillations were ~115–130 out of phase
with NADH. However, the time delay between the formation
of CO2 in the cytoplasm and its release into the external solu-
tion is not known. Therefore, we do not know which time
delay, if any, to expect between NADH and the intracellular
concentration of HCO3
-.
Overall, our results suggest that glycolysis drives the
oscillations inDcm. This is not surprising, because glycolytic
oscillations were also observed in cell-free extracts (46)
only a few years after their discovery in intact cells (18).
However, the presented work suggests that, in intact cells,
the ATPase activity of the various proton pumps in the cell
are highly important in maintaining the ability to show oscil-
lations. If the ATPase activity is significantly reduced, as
demonstrated by the effects of the inhibitors sodium azideand omeprazole, or increased, as demonstrated by the effects
of FCCP and amphotericin B, the oscillations disappear. On
the other hand, the ATPase activity seems to have no effect
on the frequency of the oscillations, such as those shown by
changes in the sugar transport activity (47). It is worth
mentioning that the coupling between glycolysis and mito-
chondrial functions might work both ways. In yeast cells
under semianaerobic conditions, oscillations in glycolysis
seem to drive oscillations in Dcm. However, it is very likely
that, under aerobic conditions, an autonomous mitochondrial
oscillator could drive oscillations in glycolysis and in other
metabolic pathways (2,14–17,24,25).
The presented results demonstrate a close coupling
between glycolysis and mitochondrial and plasma membrane
ion pumps. In our nongrowing yeast cells, many metabolic
pathways were downregulated, compared with glycolysis.
Therefore, the glycolytic system is relatively simple
compared with glycolysis in other eukaryotic cells, including
mammalian cells, and may be considered a good model
system of similar processes in other eukaryotic cells. Sugar
metabolism in S. cerevisiae has much in common with sugar
metabolism in pancreatic b cells. In these cells, glucose stim-
ulates insulin production as a consequence of being metabo-
lized. Metabolism of glucose leads to an increase in the cyto-
solic ATP/ADP ratio, which, again, through closure of ATP-
dependent Kþ channels in the plasma membrane, leads to
a depolarization of the b cell (48–51). The depolarization
increases Ca2þ influx through voltage-gated Ca2þ-channels,
and the increase in cytoplasmic Ca2þ induces release of
insulin. In normal subjectsb cells secrete insulin in a pulsatory
fashion, whereas patients with non-insulin-dependent dia-
betes lack this oscillatory insulin secretion (52,53). All cells
in an islet of Langerhans are electrically coupled (54), and
the metabolisms of individual cells are therefore synchronized
(55), similar to activity of individual yeast cells in a suspension
(22,23,56). As we have found in our study, for yeast cells,
glycolytic oscillations in b cells are also regulated by mito-
chondrial functions (55).
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